Trial Profile
Liposome-Encapsulated Doxorubicin (LED) in Hormone Refractory Prostate Carcinoma, Phase II
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Doxorubicin liposomal (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 10 Jun 2014 New trial record